| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 3.69e-06 | 40 | 118 | 5 | GO:0140662 | |
| GeneOntologyMolecularFunction | CTP binding | 3.46e-05 | 2 | 118 | 2 | GO:0002135 | |
| GeneOntologyMolecularFunction | P-type manganese transporter activity | 3.46e-05 | 2 | 118 | 2 | GO:0140613 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | HSPD1 DDX59 ATP2C1 CHD5 ATP2C2 ATP5F1A SMC1B HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 6.18e-05 | 441 | 118 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | protein folding chaperone | 7.21e-05 | 73 | 118 | 5 | GO:0044183 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 8.12e-05 | 39 | 118 | 4 | GO:0097718 | |
| GeneOntologyMolecularFunction | sulfonylurea receptor binding | 1.03e-04 | 3 | 118 | 2 | GO:0017098 | |
| GeneOntologyMolecularFunction | UTP binding | 2.06e-04 | 4 | 118 | 2 | GO:0002134 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | HSPD1 DDX59 MYO1D ATP2C1 CHD5 ATP2C2 ATP5F1A SMC1B HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 2.82e-04 | 614 | 118 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | pyrimidine ribonucleotide binding | 3.42e-04 | 5 | 118 | 2 | GO:0032557 | |
| GeneOntologyMolecularFunction | dATP binding | 3.42e-04 | 5 | 118 | 2 | GO:0032564 | |
| GeneOntologyMolecularFunction | adenyl deoxyribonucleotide binding | 5.11e-04 | 6 | 118 | 2 | GO:0032558 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | HSPD1 HBS1L DDX59 ARL11 ATP2C1 CHD5 ATP2C2 ATP5F1A SMC1B HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 6.69e-04 | 775 | 118 | 13 | GO:0017111 |
| GeneOntologyMolecularFunction | purine deoxyribonucleotide binding | 7.13e-04 | 7 | 118 | 2 | GO:0032554 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 9.15e-04 | 126 | 118 | 5 | GO:0051082 | |
| GeneOntologyMolecularFunction | TPR domain binding | 9.47e-04 | 8 | 118 | 2 | GO:0030911 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 1.18e-03 | 78 | 118 | 4 | GO:0003725 | |
| GeneOntologyMolecularFunction | deoxyribonucleotide binding | 1.21e-03 | 9 | 118 | 2 | GO:0032552 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | HSPD1 HBS1L DDX59 ARL11 ATP2C1 CHD5 ATP2C2 ATP5F1A SMC1B HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 1.38e-03 | 839 | 118 | 13 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | HSPD1 HBS1L DDX59 ARL11 ATP2C1 CHD5 ATP2C2 ATP5F1A SMC1B HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 1.39e-03 | 840 | 118 | 13 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | HSPD1 HBS1L DDX59 ARL11 ATP2C1 CHD5 ATP2C2 ATP5F1A SMC1B HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 1.39e-03 | 840 | 118 | 13 | GO:0016818 |
| GeneOntologyMolecularFunction | manganese ion transmembrane transporter activity | 1.51e-03 | 10 | 118 | 2 | GO:0005384 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 1.51e-03 | 10 | 118 | 2 | GO:0030235 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 1.81e-03 | 147 | 118 | 5 | GO:0042826 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.84e-03 | 11 | 118 | 2 | GO:0005388 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide binding | 1.84e-03 | 11 | 118 | 2 | GO:0019103 | |
| GeneOntologyMolecularFunction | enoyl-CoA hydratase activity | 2.20e-03 | 12 | 118 | 2 | GO:0004300 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside monophosphate metabolic process | 6.41e-06 | 48 | 113 | 5 | GO:0009167 | |
| GeneOntologyBiologicalProcess | purine nucleoside monophosphate metabolic process | 8.67e-06 | 51 | 113 | 5 | GO:0009126 | |
| GeneOntologyBiologicalProcess | ribonucleoside monophosphate metabolic process | 3.33e-05 | 67 | 113 | 5 | GO:0009161 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | IDH1 GMPR2 CPS1 NT5C1B PARP10 LRGUK GUCA1A DLAT AK2 PC OGA URAD PYCR3 ATP5F1A | 7.80e-05 | 767 | 113 | 14 | GO:0055086 |
| GeneOntologyBiologicalProcess | purine ribonucleoside monophosphate catabolic process | 1.03e-04 | 17 | 113 | 3 | GO:0009169 | |
| GeneOntologyBiologicalProcess | purine nucleoside monophosphate catabolic process | 1.23e-04 | 18 | 113 | 3 | GO:0009128 | |
| GeneOntologyBiologicalProcess | nucleoside monophosphate metabolic process | 1.23e-04 | 88 | 113 | 5 | GO:0009123 | |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | IDH1 GMPR2 NT5C1B PARP10 LRGUK GUCA1A DLAT AK2 PC OGA URAD ATP5F1A | 1.50e-04 | 619 | 113 | 12 | GO:0006163 |
| GeneOntologyCellularComponent | secretory granule | HSPD1 SPATA31A7 CPA3 IDH1 CAV2 CREG1 TRIP11 SPATA31A5 F13A1 LRGUK ATP2C1 SPATA31A1 CEP131 FRMPD3 PCDH7 VPS13B HSP90AA1 HSP90AB1 | 1.51e-05 | 1014 | 118 | 18 | GO:0030141 |
| GeneOntologyCellularComponent | acrosomal vesicle | SPATA31A7 CAV2 TRIP11 SPATA31A5 LRGUK SPATA31A1 CEP131 VPS13B | 2.25e-05 | 206 | 118 | 8 | GO:0001669 |
| GeneOntologyCellularComponent | secretory vesicle | HSPD1 SPATA31A7 CPA3 IDH1 CAV2 CREG1 TRIP11 SPATA31A5 F13A1 LRGUK ATP2C1 SPATA31A1 CEP131 FRMPD3 PCDH7 VPS13B STX6 HSP90AA1 HSP90AB1 | 6.87e-05 | 1246 | 118 | 19 | GO:0099503 |
| GeneOntologyCellularComponent | sperm plasma membrane | 2.50e-04 | 22 | 118 | 3 | GO:0097524 | |
| GeneOntologyCellularComponent | sperm mitochondrial sheath | 6.51e-04 | 7 | 118 | 2 | GO:0097226 | |
| Domain | P-type_ATPase_IIA_PMR1 | 3.56e-05 | 2 | 112 | 2 | IPR006413 | |
| Domain | Heat_shock_protein_90_CS | 1.07e-04 | 3 | 112 | 2 | IPR019805 | |
| Domain | Hsp90_fam | 2.12e-04 | 4 | 112 | 2 | IPR001404 | |
| Domain | Hsp90_N | 2.12e-04 | 4 | 112 | 2 | IPR020575 | |
| Domain | HSP90 | 2.12e-04 | 4 | 112 | 2 | PF00183 | |
| Domain | HSP90 | 2.12e-04 | 4 | 112 | 2 | PS00298 | |
| Domain | Autophagy-rel_C | 3.52e-04 | 5 | 112 | 2 | IPR015412 | |
| Domain | ATG_C | 3.52e-04 | 5 | 112 | 2 | PF09333 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 7.34e-04 | 7 | 112 | 2 | IPR005479 | |
| Domain | BC-like_N | 7.34e-04 | 7 | 112 | 2 | IPR005481 | |
| Domain | CPSase_L_D2 | 7.34e-04 | 7 | 112 | 2 | PF02786 | |
| Domain | Biotin_carb_N | 7.34e-04 | 7 | 112 | 2 | PF00289 | |
| Domain | IQ | 8.74e-04 | 71 | 112 | 4 | PF00612 | |
| Domain | Chorein_N | 9.75e-04 | 8 | 112 | 2 | PF12624 | |
| Domain | VPS13_N | 9.75e-04 | 8 | 112 | 2 | IPR026854 | |
| Domain | Biotin_lipoyl | 1.25e-03 | 9 | 112 | 2 | PF00364 | |
| Domain | IQ | 1.43e-03 | 81 | 112 | 4 | SM00015 | |
| Domain | BIOTINYL_LIPOYL | 1.55e-03 | 10 | 112 | 2 | PS50968 | |
| Domain | Biotin_lipoyl | 1.55e-03 | 10 | 112 | 2 | IPR000089 | |
| Domain | - | 1.76e-03 | 40 | 112 | 3 | 3.40.630.30 | |
| Domain | IQ_motif_EF-hand-BS | 2.11e-03 | 90 | 112 | 4 | IPR000048 | |
| Domain | Single_hybrid_motif | 2.26e-03 | 12 | 112 | 2 | IPR011053 | |
| Domain | DUF4599 | 2.26e-03 | 12 | 112 | 2 | PF15371 | |
| Domain | DUF4599 | 2.26e-03 | 12 | 112 | 2 | IPR027970 | |
| Domain | IQ | 2.37e-03 | 93 | 112 | 4 | PS50096 | |
| Domain | Cyt_P450_E_grp-I | 2.48e-03 | 45 | 112 | 3 | IPR002401 | |
| Domain | Acyl_CoA_acyltransferase | 2.48e-03 | 45 | 112 | 3 | IPR016181 | |
| Domain | FERM_M | 2.64e-03 | 46 | 112 | 3 | PF00373 | |
| Domain | - | 2.66e-03 | 13 | 112 | 2 | 3.40.50.20 | |
| Domain | ATP_GRASP | 3.09e-03 | 14 | 112 | 2 | PS50975 | |
| Domain | ATP-grasp | 3.09e-03 | 14 | 112 | 2 | IPR011761 | |
| Domain | PreATP-grasp_dom | 3.09e-03 | 14 | 112 | 2 | IPR016185 | |
| Domain | FERM_central | 3.16e-03 | 49 | 112 | 3 | IPR019748 | |
| Domain | FERM_domain | 3.16e-03 | 49 | 112 | 3 | IPR000299 | |
| Domain | FERM_1 | 3.35e-03 | 50 | 112 | 3 | PS00660 | |
| Domain | FERM_2 | 3.35e-03 | 50 | 112 | 3 | PS00661 | |
| Domain | FERM_3 | 3.35e-03 | 50 | 112 | 3 | PS50057 | |
| Domain | Band_41_domain | 3.35e-03 | 50 | 112 | 3 | IPR019749 | |
| Domain | B41 | 3.35e-03 | 50 | 112 | 3 | SM00295 | |
| Domain | - | 3.56e-03 | 15 | 112 | 2 | 3.30.1490.20 | |
| Domain | ATPase_P-typ_TM_dom | 4.05e-03 | 16 | 112 | 2 | IPR023298 | |
| Domain | - | 4.05e-03 | 16 | 112 | 2 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 4.57e-03 | 17 | 112 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 4.57e-03 | 17 | 112 | 2 | PF00689 | |
| Domain | - | 5.10e-03 | 58 | 112 | 3 | 1.10.630.10 | |
| Domain | p450 | 5.10e-03 | 58 | 112 | 3 | PF00067 | |
| Domain | ATP_grasp_subdomain_1 | 5.12e-03 | 18 | 112 | 2 | IPR013815 | |
| Domain | Cation_ATPase_N | 5.12e-03 | 18 | 112 | 2 | PF00690 | |
| Domain | - | 5.12e-03 | 18 | 112 | 2 | 3.30.470.20 | |
| Domain | HATPase_c | 5.12e-03 | 18 | 112 | 2 | SM00387 | |
| Domain | Cation_ATPase_N | 5.12e-03 | 18 | 112 | 2 | SM00831 | |
| Domain | Cyt_P450 | 5.60e-03 | 60 | 112 | 3 | IPR001128 | |
| Domain | 6-PGluconate_DH_C-like | 5.70e-03 | 19 | 112 | 2 | IPR008927 | |
| Domain | HATPase_c | 5.70e-03 | 19 | 112 | 2 | PF02518 | |
| Domain | ATPase_P-typ_cation-transptr_N | 5.70e-03 | 19 | 112 | 2 | IPR004014 | |
| Pubmed | HSPD1 HACD3 LAMA4 IDH1 CREG1 ECHS1 HIBADH YWHAB LRPPRC DLAT AK2 COA7 ATP5F1A NEK11 STX6 HSP90AA1 HSP90AB1 | 5.51e-09 | 859 | 118 | 17 | 31536960 | |
| Pubmed | HSPD1 HACD3 SYNE1 ECHS1 SNX19 ARMC1 AKAP12 CACTIN LRPPRC PTPN13 ERAP2 ARHGEF10 TMEM131L DLAT CEP131 OGA PCDH7 COA7 PYCR3 VPS13B FAM177A1 | 2.79e-08 | 1487 | 118 | 21 | 33957083 | |
| Pubmed | HSPD1 HBS1L AGO2 MYO1D RC3H1 LARP1 YWHAB LRPPRC PYCR3 EIF3M ATP5F1A HSP90AA1 | 7.38e-08 | 469 | 118 | 12 | 37314180 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | HSPD1 AGO2 HACD3 SYNE1 LARP1 IQCN IDH1 ECHS1 YWHAB LRPPRC AK2 PC ATP5F1A HSP90AA1 HSP90AB1 | 1.06e-07 | 807 | 118 | 15 | 30575818 |
| Pubmed | HSPD1 HBS1L MYO1D HACD3 LARP1 RANBP6 ELP3 YWHAB LRPPRC SPIN1 DLAT PC PYCR3 EIF3M ATP5F1A HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 1.24e-07 | 1335 | 118 | 19 | 29229926 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | AGO2 HACD3 KAT6A HECTD4 LARP1 IQCN GRHL2 PARP10 LRPPRC SLC25A36 TNRC18 PTPN13 ATP2C1 NACC2 SPIN1 CAMTA1 FGGY EIF3M VPS13B NOTCH3 | 1.40e-07 | 1489 | 118 | 20 | 28611215 |
| Pubmed | Mapping of the gene family for human heat-shock protein 90 alpha to chromosomes 1, 4, 11, and 14. | 1.52e-07 | 4 | 118 | 3 | 1740332 | |
| Pubmed | HSPD1 KAT6A ECHS1 LRPPRC CFAP54 DLAT AK2 ATP5F1A VPS13B HSP90AB1 | 2.09e-07 | 331 | 118 | 10 | 29199018 | |
| Pubmed | The HSP90 family of genes in the human genome: insights into their divergence and evolution. | 2.22e-07 | 16 | 118 | 4 | 16269234 | |
| Pubmed | Mitochondrial protein interactome elucidated by chemical cross-linking mass spectrometry. | HSPD1 CYP11A1 CPS1 ECHS1 HIBADH LRPPRC DLAT AK2 COA7 ATP5F1A | 2.90e-07 | 343 | 118 | 10 | 28130547 |
| Pubmed | 4.09e-07 | 83 | 118 | 6 | 35124280 | ||
| Pubmed | 4.34e-07 | 274 | 118 | 9 | 34244482 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | HSPD1 GPAA1 HACD3 CYP20A1 IDH1 GMPR2 ECHS1 HIBADH YWHAB TRIP11 F13A1 PARP10 LRPPRC DLAT AK2 PYCR3 ATP5F1A HSP90AA1 HSP90AB1 | 4.41e-07 | 1451 | 118 | 19 | 30550785 |
| Pubmed | HSPD1 HBS1L AGO2 GPAA1 CYP20A1 DGKA LARP1 YWHAB LRPPRC ATP2C1 CHD5 OGA MED13 ATP5F1A IL6ST HSP90AA1 HSP90AB1 | 4.49e-07 | 1168 | 118 | 17 | 19946888 | |
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | 4.96e-07 | 203 | 118 | 8 | 16916647 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | HSPD1 MYO1D HACD3 CPS1 LRPPRC ATP2C1 PC PYCR3 ATP5F1A HSP90AA1 HSP90AA2P HSP90AB1 | 5.38e-07 | 565 | 118 | 12 | 33567341 |
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | HSPD1 ECHS1 HIBADH YWHAB LRPPRC PC PYCR3 ATP5F1A HSP90AA1 HSP90AA2P HSP90AB1 | 6.12e-07 | 468 | 118 | 11 | 36042349 |
| Pubmed | Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | 6.40e-07 | 210 | 118 | 8 | 26217791 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | HSPD1 ATG2B LARP1 IDH1 TRIP11 AKAP12 SCML2 PTPN13 AK2 TAF6 PC OGA ATP5F1A HSP90AA1 HSP90AB1 | 6.73e-07 | 934 | 118 | 15 | 33916271 |
| Pubmed | 7.56e-07 | 6 | 118 | 3 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 7.56e-07 | 6 | 118 | 3 | 25930072 | |
| Pubmed | 8.78e-07 | 22 | 118 | 4 | 26767982 | ||
| Pubmed | 1.04e-06 | 53 | 118 | 5 | 15047060 | ||
| Pubmed | SYNE1 LAMA4 CCDC141 TRIP11 AKAP12 LRPPRC MED13 IL6ST NOTCH3 HSP90AA1 HSP90AB1 | 1.10e-06 | 497 | 118 | 11 | 23414517 | |
| Pubmed | 1.11e-06 | 156 | 118 | 7 | 22952844 | ||
| Pubmed | 1.27e-06 | 312 | 118 | 9 | 37120454 | ||
| Pubmed | Messenger RNA expression of heat shock proteins (HSPs) during ocular development. | 1.32e-06 | 7 | 118 | 3 | 8974842 | |
| Pubmed | HACD3 RANBP6 AKAP12 LRPPRC SPIN1 DLAT EIF3M ATP5F1A HSP90AA1 HSP90AB1 | 1.40e-06 | 408 | 118 | 10 | 33766124 | |
| Pubmed | HSPD1 ASRGL1 HACD3 ATG2B ECHS1 FABP7 LRPPRC TNRC18 ATP2C1 DLAT TLN2 CEP131 PC FAM177A1 HSP90AA1 HSP90AB1 | 1.60e-06 | 1139 | 118 | 16 | 36417873 | |
| Pubmed | HSPD1 CYP11A1 CYP24A1 ECHS1 HIBADH LRPPRC DLAT AK2 PC ATP5F1A HSP90AB1 | 2.54e-06 | 542 | 118 | 11 | 14651853 | |
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | HSPD1 CYP11A1 CYP24A1 IDH1 CPS1 ECHS1 HIBADH ARMC1 LRPPRC SLC25A36 DLAT AK2 PC ATP5F1A | 3.28e-06 | 926 | 118 | 14 | 20877624 |
| Pubmed | Quantitative study of the interactome of PKCζ involved in the EGF-induced tumor cell chemotaxis. | 3.33e-06 | 184 | 118 | 7 | 23402259 | |
| Pubmed | ZFP36L2 is a cell cycle-regulated CCCH protein necessary for DNA lesion-induced S-phase arrest. | 3.97e-06 | 189 | 118 | 7 | 29449217 | |
| Pubmed | HBS1L ZNF473 DGKA BBS4 F13A1 AKAP12 SEPSECS SCML2 PTPN13 SPIN1 TMEM131L CRYBG1 CAMTA1 ATP5F1A VPS13B | 4.18e-06 | 1084 | 118 | 15 | 11544199 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | HSPD1 SYNE1 LARP1 CPS1 CACTIN LRPPRC CHD5 TAF6 PC ATP5F1A HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 4.34e-06 | 949 | 118 | 14 | 36574265 |
| Pubmed | BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites. | 5.16e-06 | 73 | 118 | 5 | 32347575 | |
| Pubmed | HSPD1 HBS1L HACD3 ATG2B LARP1 AKAP12 LRPPRC PTPN13 PCDH7 ATP5F1A HSP90AA1 HSP90AB1 | 5.51e-06 | 708 | 118 | 12 | 39231216 | |
| Pubmed | 6.20e-06 | 132 | 118 | 6 | 22496890 | ||
| Pubmed | HSPD1 ASRGL1 AGO2 MYO1D HACD3 SYNE1 LARP1 ELP3 YWHAB TRIP11 LRPPRC DLAT TLN2 PC ATP5F1A HSP90AA1 HSP90AB1 | 6.93e-06 | 1431 | 118 | 17 | 37142655 | |
| Pubmed | Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. | HSPD1 CYP11A1 CYP24A1 RANBP6 CPS1 ECHS1 HIBADH ARMC1 LRPPRC SLC25A36 DLAT AK2 PC COA7 ATP5F1A | 7.33e-06 | 1136 | 118 | 15 | 34800366 |
| Pubmed | MKRN3 ZNF473 SYNE1 HECTD4 YWHAB TRIP11 PTPN13 ARHGEF10 DLAT TLN2 TAF6 PC MED13 ATP5F1A HSP90AA1 HSP90AB1 | 7.41e-06 | 1285 | 118 | 16 | 35914814 | |
| Pubmed | 8.19e-06 | 12 | 118 | 3 | 20642453 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HSPD1 LARP1 IDH1 ECHS1 YWHAB AKAP12 LRPPRC SPIN1 DLAT AK2 OGA PYCR3 ATP5F1A HSP90AA1 HSP90AB1 | 8.39e-06 | 1149 | 118 | 15 | 35446349 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HSPD1 HBS1L LARP1 RANBP6 IDH1 GMPR2 ECHS1 ELP3 YWHAB AKAP12 ARHGEF10 OGA PYCR3 EIF3M HSP90AA1 HSP90AA4P HSP90AB1 | 8.61e-06 | 1455 | 118 | 17 | 22863883 |
| Pubmed | HSPD1 CYP20A1 IDH1 YWHAB AKAP12 LRPPRC SLC25A36 DLAT PYCR3 EIF3M ATP5F1A HSP90AA1 HSP90AB1 | 9.40e-06 | 878 | 118 | 13 | 37223481 | |
| Pubmed | MKRN3 HSPD1 AGO2 RBM12B SYNE1 YWHAB TRIP11 ATP2C1 SPIN1 AK2 OGA EIF3M | 1.04e-05 | 754 | 118 | 12 | 35906200 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 10376793 | ||
| Pubmed | Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target. | 1.14e-05 | 2 | 118 | 2 | 33179566 | |
| Pubmed | Secretory pathway Ca2+ -ATPases promote in vitro microcalcifications in breast cancer cells. | 1.14e-05 | 2 | 118 | 2 | 28618103 | |
| Pubmed | Regulation of embryonic stem cell pluripotency by heat shock protein 90. | 1.14e-05 | 2 | 118 | 2 | 22696450 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 22895790 | ||
| Pubmed | Hsp90 is cleaved by reactive oxygen species at a highly conserved N-terminal amino acid motif. | 1.14e-05 | 2 | 118 | 2 | 22848402 | |
| Pubmed | Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylase. | 1.14e-05 | 2 | 118 | 2 | 25243911 | |
| Pubmed | Expression of Hsp90 chaperone [corrected] proteins in human tumor tissue. | 1.14e-05 | 2 | 118 | 2 | 19576239 | |
| Pubmed | A mouse tumor-specific transplantation antigen is a heat shock-related protein. | 1.14e-05 | 2 | 118 | 2 | 3458168 | |
| Pubmed | Mechanism of dimer formation of the 90-kDa heat-shock protein. | 1.14e-05 | 2 | 118 | 2 | 7588731 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 2925609 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 19656872 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 2469626 | ||
| Pubmed | Cloning and analysis of a human 86-kDa heat-shock-protein-encoding gene. | 1.14e-05 | 2 | 118 | 2 | 2591742 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 33080545 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 31885746 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 37011862 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 26651243 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 36270993 | ||
| Pubmed | Hsp90 regulation of fibroblast activation in pulmonary fibrosis. | 1.14e-05 | 2 | 118 | 2 | 28239659 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 37028636 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 37406487 | ||
| Pubmed | Expression and therapeutic relevance of heat-shock protein 90 in pancreatic endocrine tumors. | 1.14e-05 | 2 | 118 | 2 | 22194440 | |
| Pubmed | Circadian expression of 86- and 84-kDa heat shock proteins in the mouse suprachiasmatic nucleus. | 1.14e-05 | 2 | 118 | 2 | 18480550 | |
| Pubmed | Hsp90 regulates the function of argonaute 2 and its recruitment to stress granules and P-bodies. | 1.14e-05 | 2 | 118 | 2 | 19458189 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 22841823 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 16332677 | ||
| Pubmed | Substitution of only two residues of human Hsp90alpha causes impeded dimerization of Hsp90beta. | 1.14e-05 | 2 | 118 | 2 | 18347946 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 19047110 | ||
| Pubmed | Conserved conformational changes in the ATPase cycle of human Hsp90. | 1.14e-05 | 2 | 118 | 2 | 18400751 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 22019372 | ||
| Pubmed | Heat shock protein HSP86 expression during mouse embryo development, especially in the germ-line. | 1.14e-05 | 2 | 118 | 2 | 12136260 | |
| Pubmed | HSP90 protein stabilizes unloaded argonaute complexes and microscopic P-bodies in human cells. | 1.14e-05 | 2 | 118 | 2 | 20237157 | |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 1.28e-05 | 315 | 118 | 8 | 26777405 | |
| Pubmed | AGO2 MYO1D ELP3 YWHAB SNX19 CACTIN PTPN13 AK2 CEP131 PC PCDH7 ATP5F1A HSP90AA1 HSP90AB1 | 1.34e-05 | 1049 | 118 | 14 | 27880917 | |
| Pubmed | Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. | HSPD1 HACD3 YWHAB LRPPRC TLN2 PYCR3 ATP5F1A HSP90AA1 HSP90AB1 | 1.35e-05 | 418 | 118 | 9 | 32552912 |
| Pubmed | 1.68e-05 | 15 | 118 | 3 | 17400507 | ||
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | 1.87e-05 | 332 | 118 | 8 | 30595499 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 1.91e-05 | 333 | 118 | 8 | 32665550 | |
| Pubmed | HSPD1 LARP1 YWHAB LRPPRC SPIN1 DLAT PYCR3 ATP5F1A HSP90AA1 HSP90AB1 | 1.94e-05 | 551 | 118 | 10 | 34728620 | |
| Pubmed | HSPD1 AGO2 IDH1 ECHS1 HIBADH YWHAB DLAT ATP5F1A HSP90AA1 HSP90AB1 | 1.97e-05 | 552 | 118 | 10 | 36293380 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | AGO2 HACD3 RC3H1 LARP1 YWHAB CACTIN LRPPRC SPIN1 ATP5F1A HSP90AA1 HSP90AB1 | 2.07e-05 | 678 | 118 | 11 | 30209976 |
| Pubmed | 2.18e-05 | 98 | 118 | 5 | 26561776 | ||
| Pubmed | 2.32e-05 | 248 | 118 | 7 | 32963011 | ||
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 2.40e-05 | 344 | 118 | 8 | 36282215 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HSPD1 HBS1L DDX59 HACD3 LARP1 CPS1 ELP3 YWHAB LRPPRC DLAT AK2 PC EIF3M ATP5F1A HSP90AA1 HSP90AB1 | 2.42e-05 | 1415 | 118 | 16 | 28515276 |
| Pubmed | AGO2 SYNE1 HECTD4 YWHAB TRIP11 AKAP12 LRPPRC ZKSCAN1 TLN2 CEP131 FRMPD3 HSP90AA1 HSP90AB1 | 2.48e-05 | 963 | 118 | 13 | 28671696 | |
| Pubmed | Interactome dynamics of RAF1-BRAF kinase monomers and dimers. | 2.50e-05 | 17 | 118 | 3 | 37045861 | |
| Pubmed | 2.57e-05 | 50 | 118 | 4 | 26275350 | ||
| Pubmed | 2.78e-05 | 51 | 118 | 4 | 36896912 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | HSPD1 MYO1D HACD3 LARP1 YWHAB CACTIN TAF6 EIF3M ATP5F1A HSP90AA1 HSP90AB1 | 2.80e-05 | 701 | 118 | 11 | 30196744 |
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 2.90e-05 | 104 | 118 | 5 | 36055981 | |
| Pubmed | 2.99e-05 | 18 | 118 | 3 | 38266827 | ||
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 3.08e-05 | 175 | 118 | 6 | 25756610 | |
| Interaction | EIF4B interactions | HSPD1 AGO2 RBM12B RC3H1 KAT6A LARP1 YWHAB KCNJ2 OGA PCDH7 EIF3M ATP5F1A HSP90AA1 | 5.60e-07 | 402 | 116 | 13 | int:EIF4B |
| Interaction | RICTOR interactions | HSPD1 HBS1L ZNF473 MYO1D ATG2B IDH1 CPS1 YWHAB LRPPRC SPIN1 PC OGA ATP5F1A STX6 HSP90AA1 HSP90AA2P HSP90AB1 | 1.61e-06 | 759 | 116 | 17 | int:RICTOR |
| Interaction | GLDC interactions | HSPD1 AGO2 MYO1D RC3H1 LARP1 LRPPRC PCDH7 PYCR3 ATP5F1A HSP90AA1 HSP90AB1 | 2.51e-06 | 321 | 116 | 11 | int:GLDC |
| Interaction | ACADM interactions | 6.10e-06 | 169 | 116 | 8 | int:ACADM | |
| Interaction | ATG16L1 interactions | HSPD1 MYO1D HACD3 ATG2B LARP1 RANBP6 CAV2 YWHAB TRIP11 PARP10 COLEC12 CACTIN PTPN13 CEP131 TAF6 EIF3M ATP5F1A STX6 HSP90AA1 HSP90AB1 | 9.76e-06 | 1161 | 116 | 20 | int:ATG16L1 |
| Interaction | ACAA2 interactions | 1.73e-05 | 195 | 116 | 8 | int:ACAA2 | |
| Interaction | PDK4 interactions | 1.75e-05 | 56 | 116 | 5 | int:PDK4 | |
| Interaction | DNAJC4 interactions | 1.91e-05 | 57 | 116 | 5 | int:DNAJC4 | |
| Interaction | STK35 interactions | 2.54e-05 | 30 | 116 | 4 | int:STK35 | |
| Interaction | LHPP interactions | 5.94e-05 | 37 | 116 | 4 | int:LHPP | |
| Interaction | AASS interactions | 6.80e-05 | 74 | 116 | 5 | int:AASS | |
| Interaction | BGLT3 interactions | 7.25e-05 | 75 | 116 | 5 | int:BGLT3 | |
| Interaction | GSK3A interactions | HBS1L ATG2B YWHAB PARP10 TNRC18 PTPN13 CRYBG1 AK2 CEP131 HSP90AA1 HSP90AB1 | 7.67e-05 | 464 | 116 | 11 | int:GSK3A |
| Interaction | STK38L interactions | 8.23e-05 | 77 | 116 | 5 | int:STK38L | |
| Interaction | GRK5 interactions | 8.89e-05 | 182 | 116 | 7 | int:GRK5 | |
| Interaction | AGR2 interactions | HSPD1 AGO2 HACD3 SYNE1 LARP1 IQCN IDH1 ECHS1 YWHAB LRPPRC GUCA1A AK2 PC ATP5F1A HSP90AA1 HSP90AB1 | 8.94e-05 | 934 | 116 | 16 | int:AGR2 |
| Interaction | EIF4E2 interactions | 8.99e-05 | 246 | 116 | 8 | int:EIF4E2 | |
| Interaction | ATP2C2 interactions | 9.82e-05 | 3 | 116 | 2 | int:ATP2C2 | |
| Interaction | TSSK1B interactions | 1.18e-04 | 44 | 116 | 4 | int:TSSK1B | |
| Interaction | PPT1 interactions | 1.18e-04 | 256 | 116 | 8 | int:PPT1 | |
| Interaction | AURKB interactions | HSPD1 HACD3 RBM12B LARP1 CPS1 LRPPRC AK2 CEP131 EIF3M ATP5F1A HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 1.22e-04 | 761 | 116 | 14 | int:AURKB |
| Interaction | HSP90AB1 interactions | HSPD1 DDX59 AGO2 CPS1 YWHAB LRPPRC BMX TNRC18 MAPK13 PCDH7 ATP5F1A NEK11 HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 1.23e-04 | 960 | 116 | 16 | int:HSP90AB1 |
| Interaction | USP48 interactions | HSPD1 AGO2 LARP1 CPA3 IDH1 ECHS1 HIBADH YWHAB DLAT OGA ATP5F1A HSP90AA1 HSP90AB1 | 1.24e-04 | 668 | 116 | 13 | int:USP48 |
| Interaction | HCK interactions | 1.28e-04 | 193 | 116 | 7 | int:HCK | |
| Interaction | EPHA6 interactions | 1.29e-04 | 45 | 116 | 4 | int:EPHA6 | |
| Interaction | ESRRB interactions | 1.39e-04 | 262 | 116 | 8 | int:ESRRB | |
| Interaction | PDK2 interactions | 1.41e-04 | 46 | 116 | 4 | int:PDK2 | |
| Interaction | KCNA3 interactions | HSPD1 HBS1L MYO1D HACD3 ATG2B LARP1 AKAP12 LRPPRC PTPN13 TLN2 RP1 PCDH7 ATP5F1A HSP90AA1 HSP90AB1 | 1.43e-04 | 871 | 116 | 15 | int:KCNA3 |
| Interaction | ERBB2 interactions | HSPD1 ASRGL1 GMPR2 AKAP12 LRPPRC BMX CRYBG1 PC IL6ST STX6 HSP90AA1 HSP90AB1 | 1.50e-04 | 589 | 116 | 12 | int:ERBB2 |
| Interaction | CDK7 interactions | HSPD1 ECHS1 HIBADH YWHAB TAF6 PC PYCR3 ATP5F1A HSP90AA1 HSP90AA4P HSP90AB1 | 1.51e-04 | 501 | 116 | 11 | int:CDK7 |
| Interaction | NAA40 interactions | HSPD1 ATG2B LARP1 IDH1 YWHAB TRIP11 AKAP12 SCML2 PTPN13 AK2 TAF6 PC OGA ATP5F1A HSP90AA1 HSP90AB1 | 1.52e-04 | 978 | 116 | 16 | int:NAA40 |
| Interaction | OPTN interactions | 1.65e-04 | 422 | 116 | 10 | int:OPTN | |
| Interaction | NT5C1B interactions | 1.96e-04 | 4 | 116 | 2 | int:NT5C1B | |
| Interaction | EIF4G1 interactions | AGO2 RC3H1 LARP1 YWHAB LRPPRC PCDH7 EIF3M ATP5F1A HSP90AA1 HSP90AB1 | 2.03e-04 | 433 | 116 | 10 | int:EIF4G1 |
| Interaction | HSPB1 interactions | HSPD1 RC3H1 CAV2 YWHAB F13A1 GUCA1A SPIN1 TAF6 PC EIF3M ATP5F1A HSP90AA1 HSP90AB1 | 2.20e-04 | 708 | 116 | 13 | int:HSPB1 |
| Interaction | ZFP36L2 interactions | 2.22e-04 | 211 | 116 | 7 | int:ZFP36L2 | |
| Interaction | YWHAQ interactions | RC3H1 HECTD4 LARP1 CPS1 ECHS1 HIBADH YWHAB TRIP11 PARD6B LRPPRC PTPN13 CEP131 PC PCDH7 ATP5F1A HSP90AA1 HSP90AB1 | 2.23e-04 | 1118 | 116 | 17 | int:YWHAQ |
| Interaction | KCNG1 interactions | 2.29e-04 | 21 | 116 | 3 | int:KCNG1 | |
| Interaction | NIPSNAP3B interactions | 2.29e-04 | 21 | 116 | 3 | int:NIPSNAP3B | |
| Interaction | BTG3 interactions | 2.57e-04 | 98 | 116 | 5 | int:BTG3 | |
| Interaction | PPP1R3D interactions | 2.64e-04 | 22 | 116 | 3 | int:PPP1R3D | |
| Interaction | UNC45B interactions | 2.64e-04 | 22 | 116 | 3 | int:UNC45B | |
| Interaction | HSPH1 interactions | RC3H1 LARP1 CAV2 CPS1 YWHAB PARD6B LRPPRC BMX HSP90AA1 HSP90AB1 | 2.67e-04 | 448 | 116 | 10 | int:HSPH1 |
| Interaction | CFD interactions | HSPD1 GPAA1 HACD3 CYP20A1 IDH1 GMPR2 ECHS1 HIBADH YWHAB TRIP11 F13A1 PARP10 LRPPRC DLAT AK2 PYCR3 ATP5F1A HSP90AA1 HSP90AB1 | 2.72e-04 | 1360 | 116 | 19 | int:CFD |
| Interaction | AMHR2 interactions | 3.04e-04 | 56 | 116 | 4 | int:AMHR2 | |
| Interaction | PELO interactions | 3.41e-04 | 161 | 116 | 6 | int:PELO | |
| Interaction | STYK1 interactions | 3.41e-04 | 161 | 116 | 6 | int:STYK1 | |
| Interaction | DDX46 interactions | 3.46e-04 | 227 | 116 | 7 | int:DDX46 | |
| Interaction | ANKRD55 interactions | 3.55e-04 | 228 | 116 | 7 | int:ANKRD55 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 1.82e-04 | 8 | 118 | 2 | chr9q12 | |
| GeneFamily | Heat shock 90kDa proteins | 1.51e-04 | 5 | 71 | 2 | 586 | |
| GeneFamily | ATPases Ca2+ transporting | 5.38e-04 | 9 | 71 | 2 | 1209 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 9.96e-04 | 50 | 71 | 3 | 1293 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.99e-03 | 17 | 71 | 2 | 486 | |
| GeneFamily | PDZ domain containing | 3.01e-03 | 152 | 71 | 4 | 1220 | |
| Coexpression | WALLACE_PROSTATE_CANCER_DN | 1.67e-06 | 6 | 116 | 3 | M12533 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | HSPD1 AGO2 ZNF473 HACD3 LAMA4 IDH1 ELP3 ARMC1 LRPPRC SLC25A36 SCML2 ATP2C1 ARHGEF10 SPIN1 AK2 CAMTA1 COA7 EIF3M STX6 | 1.30e-05 | 1407 | 116 | 19 | M14427 |
| Coexpression | ONKEN_UVEAL_MELANOMA_DN | HSPD1 HACD3 LAMA4 CAV2 GMPR2 CPS1 CREG1 SLC25A36 SPIN1 OGA HSP90AB1 | 2.55e-05 | 533 | 116 | 11 | M2605 |
| Coexpression | GSE17721_CTRL_VS_LPS_12H_BMDC_UP | 3.03e-05 | 199 | 116 | 7 | M3701 | |
| Coexpression | GSE3982_MAST_CELL_VS_NKCELL_UP | 3.03e-05 | 199 | 116 | 7 | M5450 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_DN | 3.13e-05 | 200 | 116 | 7 | M7989 | |
| Coexpression | PATIL_LIVER_CANCER | AGO2 GPAA1 HACD3 RBM12B LAMA4 LARP1 F13A1 ARMC1 COLEC12 ZKSCAN1 TAF6 NOTCH3 | 3.72e-05 | 660 | 116 | 12 | M1195 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 3.85e-05 | 85 | 116 | 5 | M10575 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | 7.15e-05 | 398 | 116 | 9 | M7514 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.98e-07 | 193 | 117 | 7 | cf3cbf79ccd34ddcf06ec6194a18a7afd7f91f39 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.85e-07 | 196 | 117 | 7 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.16e-07 | 197 | 117 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 9.80e-07 | 199 | 117 | 7 | 6f159c1215439ec22374903124085746fa8da333 | |
| ToppCell | 10x5'-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 4.31e-06 | 161 | 117 | 6 | 15ba7e69699558353cfeecdcf1dbc2e147379ed6 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 4.47e-06 | 162 | 117 | 6 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.14e-06 | 166 | 117 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.14e-06 | 166 | 117 | 6 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | severe-Myeloid-Eosinophils|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.89e-06 | 170 | 117 | 6 | 863f0266d5837cdbc3e09a3fe6a99dd3e6261674 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.30e-06 | 172 | 117 | 6 | fc092a0631555d79e00ef9890cbd806e15bca2d4 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.30e-06 | 172 | 117 | 6 | 745725bd10c82017d678463b8fef0d2dcf09a8fd | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 7.42e-06 | 177 | 117 | 6 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 7.66e-06 | 178 | 117 | 6 | 9a3581a0158dfa5a1cc942f8c532afb5e38b272a | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 8.17e-06 | 180 | 117 | 6 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 8.70e-06 | 182 | 117 | 6 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 190 | 117 | 6 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-05 | 191 | 117 | 6 | a8d77095ba20b47fc70ba04f80759fbce873253d | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.14e-05 | 191 | 117 | 6 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.21e-05 | 193 | 117 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 194 | 117 | 6 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 194 | 117 | 6 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 194 | 117 | 6 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.29e-05 | 195 | 117 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 195 | 117 | 6 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.29e-05 | 195 | 117 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.29e-05 | 195 | 117 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | control-Others-CD34+_GATA2+_cells|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.33e-05 | 196 | 117 | 6 | 25994ca143701c72d2f84a3b6d348fcfa1d26a54 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 196 | 117 | 6 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 196 | 117 | 6 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-05 | 197 | 117 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Epithelial_cells-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.36e-05 | 197 | 117 | 6 | 59aa28a377315dfcda4d9b6ecd3419157654f24e | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.36e-05 | 197 | 117 | 6 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.40e-05 | 198 | 117 | 6 | 92c569c3b8a9fca2d4682cbf77ee8149bcc0a80a | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-05 | 198 | 117 | 6 | 6b8baa0b76242736f6dba482cdaad019256877ea | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-05 | 198 | 117 | 6 | 8519c7bd5f6c5a97f5e43f4729b1411d3b07e4c8 | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.44e-05 | 199 | 117 | 6 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.44e-05 | 199 | 117 | 6 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.44e-05 | 199 | 117 | 6 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.49e-05 | 200 | 117 | 6 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-05 | 200 | 117 | 6 | 4fb6fd703aca9a992924245105ad99163146a415 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.49e-05 | 200 | 117 | 6 | c2bde99b3bc7a8740441c1a0c1394892b940b857 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.49e-05 | 200 | 117 | 6 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.49e-05 | 200 | 117 | 6 | 3ff9abd5e07780a59d5571da906fa15f00a1d5c2 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.49e-05 | 200 | 117 | 6 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.49e-05 | 200 | 117 | 6 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.49e-05 | 200 | 117 | 6 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.49e-05 | 200 | 117 | 6 | 9970e9bde6aa2ff3aef60dcb065ff15b7463e147 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-05 | 200 | 117 | 6 | b50de1f8c8f598e281951e4587f2d96c11aac836 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.48e-05 | 148 | 117 | 5 | 74f1f9d1a53dc1a09cb6a504cbbdc7496c5b6879 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.93e-05 | 151 | 117 | 5 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.93e-05 | 151 | 117 | 5 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.59e-05 | 155 | 117 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.59e-05 | 155 | 117 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-05 | 156 | 117 | 5 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-05 | 156 | 117 | 5 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.49e-05 | 160 | 117 | 5 | 21f7c0337fbd99e4a20650920d8302d7318bd25e | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.89e-05 | 162 | 117 | 5 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 7.95e-05 | 167 | 117 | 5 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 7.95e-05 | 167 | 117 | 5 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 | |
| ToppCell | -Hematopoietic_Mast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.05e-05 | 32 | 117 | 3 | ca3d87cac849c1b713acd984626f214f5c8e1433 | |
| ToppCell | -Hematopoietic_Mast-Mast_cells-Mast-cells| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.05e-05 | 32 | 117 | 3 | c6b707107c661f81e5afa945dd62b37a73bfadf9 | |
| ToppCell | -Hematopoietic_Mast-Mast_cells| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.05e-05 | 32 | 117 | 3 | de636b6fbdc9368ef6ce7157acbf84e28330cd94 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.18e-05 | 168 | 117 | 5 | b08458164d270d625b8ee390122d1c2ce8c653db | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-05 | 170 | 117 | 5 | 03cb4e508356f85372a588c8d1c6babf2a012683 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 8.65e-05 | 170 | 117 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.65e-05 | 170 | 117 | 5 | adb625124832b0786a590e8f75b61e7263a1e0d4 | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 8.65e-05 | 170 | 117 | 5 | 4dedf482cd4521b3f87d2b5ae80f7a3ea8686a15 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-05 | 171 | 117 | 5 | 9498c35b2a2c3a339dc8c5d49c8ec20d8ad52753 | |
| ToppCell | control-Myeloid-Eosinophils|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.89e-05 | 171 | 117 | 5 | 82f736c33ed96c0865618e8f8eb82a5487126bdc | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 8.89e-05 | 171 | 117 | 5 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-05 | 171 | 117 | 5 | db544252f98e073e5bb4bec4a110cd58e6434435 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-05 | 172 | 117 | 5 | feaaf8ca7983d04a59ed0a7b3fb0e6d4b3a055f2 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-05 | 172 | 117 | 5 | 9adfb4a65669cc536343616637058d0a4728013f | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-05 | 172 | 117 | 5 | 8aed9c113f27d00401c272a3684495a4bc75bd0f | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 9.13e-05 | 172 | 117 | 5 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | Frontal_cortex-Macroglia|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.39e-05 | 173 | 117 | 5 | ac70145e093ef0df43811e7c67a865ccdd45a5e3 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-skeletal_muscle_satellite_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-05 | 174 | 117 | 5 | f230d23618a6487f2664efb2c677e0a4559e2bf4 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 9.64e-05 | 174 | 117 | 5 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 9.64e-05 | 174 | 117 | 5 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-05 | 175 | 117 | 5 | 1b35acece23712ab7e3f92d9d68266efd38b3ef5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.91e-05 | 175 | 117 | 5 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-05 | 175 | 117 | 5 | a9f88054e2c28d604c65ed785f63021aadb7f4c8 | |
| ToppCell | 3'_v3-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 1.02e-04 | 176 | 117 | 5 | b9da3deaf62622d47eb30b6be7548253eee95597 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-04 | 177 | 117 | 5 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-04 | 177 | 117 | 5 | 3a85aa2bf3f2fdbea57d22d68e022cb3f6c2eb65 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 179 | 117 | 5 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| ToppCell | 3'_v3-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 1.13e-04 | 180 | 117 | 5 | b37ee81b792213d6595b4ec65d04bc35d83321c7 | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.13e-04 | 180 | 117 | 5 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 1.16e-04 | 181 | 117 | 5 | 30ec4635474ee0f0ea1415ec0ba7f008d97e8c1a | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.16e-04 | 181 | 117 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | BAL-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 1.16e-04 | 181 | 117 | 5 | f370161afef2ec827a7b194c06abb9ac1a507cbb | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.19e-04 | 182 | 117 | 5 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.19e-04 | 182 | 117 | 5 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-04 | 182 | 117 | 5 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-04 | 182 | 117 | 5 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.22e-04 | 183 | 117 | 5 | 7717fce227b4e02ed41baad8ae7dd2e22bd7c13e | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 183 | 117 | 5 | 4de2082dca2569d3aac3c9b466f27971c82d302b | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 183 | 117 | 5 | a046b569bc10083d471b420eb2c6fee93437602d | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.25e-04 | 184 | 117 | 5 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | Pericytes-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.25e-04 | 184 | 117 | 5 | 3d2d55d0f22874be21665ab37da710482f77fc36 | |
| Drug | Xanthine | 4.28e-07 | 57 | 115 | 6 | ctd:D019820 | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 7.53e-07 | 198 | 115 | 9 | 7174_DN | |
| Drug | N-nitrosomorpholine | HSPD1 MYO1D IDH1 CPS1 ECHS1 FABP7 ATP2C1 AK2 PC ATP5F1A HSP90AB1 | 1.18e-06 | 338 | 115 | 11 | ctd:C002741 |
| Drug | magnesium | HSPD1 MYO1D LAMA4 DGKA IDH1 CPS1 NT5C1B ATP2C1 KCNJ2 ATP2C2 DLAT AK2 MAPK13 PC ATP5F1A NEK11 NOTCH3 SMC1B HSP90AA1 HSP90AA2P HSP90AB1 | 2.71e-06 | 1325 | 115 | 21 | CID000000888 |
| Drug | compound 9b | 2.81e-06 | 20 | 115 | 4 | CID000207510 | |
| Drug | AC1L1IZ2 | HSPD1 MYO1D CPS1 GUCA1A KCNJ2 DLAT AK2 ATP5F1A HSP90AA1 HSP90AA2P | 3.36e-06 | 304 | 115 | 10 | CID000004795 |
| Drug | NSC330499 | 4.33e-06 | 7 | 115 | 3 | CID000433447 | |
| Drug | phenyldichloroarsine | 6.90e-06 | 8 | 115 | 3 | CID000012762 | |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HG-U133A | 7.87e-06 | 199 | 115 | 8 | 365_DN | |
| Drug | 5,8-quinolinedione | 1.03e-05 | 9 | 115 | 3 | CID000388306 | |
| Drug | Pu-3 | 2.01e-05 | 11 | 115 | 3 | CID000448965 | |
| Drug | 3-amino-5-chlorobenzoic acid | 2.53e-05 | 2 | 115 | 2 | CID010986726 | |
| Drug | monocillin III | 2.53e-05 | 2 | 115 | 2 | CID006478910 | |
| Drug | pochonin A | 2.53e-05 | 2 | 115 | 2 | CID006478909 | |
| Drug | PU-H71 | 2.53e-05 | 2 | 115 | 2 | CID009549213 | |
| Drug | 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine | 2.53e-05 | 2 | 115 | 2 | DB02754 | |
| Drug | 1uyc | 2.53e-05 | 2 | 115 | 2 | CID000448969 | |
| Drug | PU-9 | 2.53e-05 | 2 | 115 | 2 | CID000448971 | |
| Drug | P u 0 | 2.53e-05 | 2 | 115 | 2 | CID000448974 | |
| Drug | 2qf6 | 2.53e-05 | 2 | 115 | 2 | CID013373715 | |
| Drug | Geldanamycin | 2.53e-05 | 2 | 115 | 2 | DB02424 | |
| Drug | CHEBI:42139 | 2.53e-05 | 2 | 115 | 2 | CID011562562 | |
| Drug | 2qfo | 2.53e-05 | 2 | 115 | 2 | CID000600769 | |
| Drug | 3eko | 2.53e-05 | 2 | 115 | 2 | CID011160307 | |
| Drug | 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE | 2.53e-05 | 2 | 115 | 2 | DB07877 | |
| Drug | 1uyi | 2.53e-05 | 2 | 115 | 2 | CID005289232 | |
| Drug | 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL | 2.53e-05 | 2 | 115 | 2 | DB07594 | |
| Drug | NSC683666 | 2.53e-05 | 2 | 115 | 2 | CID005469153 | |
| Drug | H 64 | 2.53e-05 | 2 | 115 | 2 | CID006914564 | |
| Drug | SureCN4151355 | 2.53e-05 | 2 | 115 | 2 | CID015942101 | |
| Drug | 1alpha,20-dihydroxyvitamin D3 | 2.53e-05 | 2 | 115 | 2 | ctd:C539020 | |
| Drug | Phlorhizin | 2.62e-05 | 235 | 115 | 8 | ctd:D010695 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 5.00e-05 | 189 | 115 | 7 | 5203_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 5.35e-05 | 191 | 115 | 7 | 4283_DN | |
| Drug | AC1L9PMA | 5.46e-05 | 15 | 115 | 3 | CID000451405 | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; PC3; HT_HG-U133A | 5.90e-05 | 194 | 115 | 7 | 3717_DN | |
| Drug | Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A | 5.90e-05 | 194 | 115 | 7 | 5255_DN | |
| Drug | Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 6.50e-05 | 197 | 115 | 7 | 3528_DN | |
| Drug | diethylene glycol | 6.77e-05 | 84 | 115 | 5 | CID000008117 | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 6.93e-05 | 199 | 115 | 7 | 7020_DN | |
| Drug | NADP(H | CYP11A1 CYP24A1 IDH1 GMPR2 ECHS1 HIBADH DLAT PC PYCR3 HSP90AA1 HSP90AA2P | 7.49e-05 | 527 | 115 | 11 | CID000000930 |
| Drug | pochonin D | 7.56e-05 | 3 | 115 | 2 | CID006478913 | |
| Drug | azaquinone | 7.56e-05 | 3 | 115 | 2 | CID000099132 | |
| Drug | Radicicol | 7.56e-05 | 3 | 115 | 2 | DB03758 | |
| Drug | d 1 v | 7.56e-05 | 3 | 115 | 2 | CID000683940 | |
| Drug | AC1MD0RC | 7.56e-05 | 3 | 115 | 2 | CID002829073 | |
| Drug | HM-9 | 7.56e-05 | 3 | 115 | 2 | CID000433437 | |
| Drug | Glyoxylspermidine | 7.56e-05 | 3 | 115 | 2 | CID000133564 | |
| Drug | tienilic acid | 1.10e-04 | 93 | 115 | 5 | CID000038409 | |
| Drug | NCI60_002052 | 1.34e-04 | 20 | 115 | 3 | CID006801032 | |
| Drug | dimethyl pimelimidate | 1.34e-04 | 20 | 115 | 3 | CID000065403 | |
| Drug | N-(5-methylisoxazol-3-yl)-2-(4-(thiophen-2-yl)-6-(trifluoromethyl)pyrimidin-2-ylthio)acetamide | 1.51e-04 | 4 | 115 | 2 | ctd:C576667 | |
| Drug | uranyl chloride | 1.51e-04 | 4 | 115 | 2 | CID000082259 | |
| Drug | methoxyhydroquinone | 1.51e-04 | 4 | 115 | 2 | CID000069988 | |
| Drug | 11p110 | 1.51e-04 | 4 | 115 | 2 | CID002382787 | |
| Drug | Ab-9 | 1.56e-04 | 21 | 115 | 3 | CID006540280 | |
| Drug | beryllium fluoride | 1.78e-04 | 103 | 115 | 5 | CID000024589 | |
| Drug | tamoxifen aziridine | 1.80e-04 | 22 | 115 | 3 | CID003033894 | |
| Drug | CCT018159 | 1.80e-04 | 22 | 115 | 3 | CID005327091 | |
| Drug | 2-butenedioate | 1.89e-04 | 234 | 115 | 7 | CID000000723 | |
| Drug | beta-NADP | CYP11A1 CYP24A1 IDH1 GMPR2 HIBADH DLAT PC PYCR3 HSP90AA1 HSP90AA2P | 1.93e-04 | 490 | 115 | 10 | CID000000929 |
| Drug | S2A | 2.07e-04 | 23 | 115 | 3 | CID016058643 | |
| Disease | Leigh syndrome | 3.27e-06 | 8 | 116 | 3 | cv:C0023264 | |
| Disease | Endotoxemia | 3.27e-06 | 8 | 116 | 3 | C0376618 | |
| Disease | isobutyrylglycine measurement | 9.15e-05 | 4 | 116 | 2 | EFO_0800029 | |
| Disease | cancer (implicated_via_orthology) | 9.47e-05 | 268 | 116 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | urolithiasis | 1.13e-04 | 63 | 116 | 4 | MONDO_0024647 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 2.27e-04 | 6 | 116 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | arteriosclerosis (is_implicated_in) | 2.46e-04 | 31 | 116 | 3 | DOID:2349 (is_implicated_in) | |
| Disease | serum metabolite measurement | ASRGL1 GPAA1 CYP24A1 CPS1 ECHS1 GRHL2 F13A1 LRPPRC KCNT2 ERAP2 TLN2 PYCR3 | 3.53e-04 | 945 | 116 | 12 | EFO_0005653 |
| Disease | mean corpuscular hemoglobin concentration | HBS1L AGO2 GPAA1 HACD3 HECTD4 LARP1 GMPR2 CPS1 COLEC12 PYCR3 MED13 VPS13B HSP90AB1 | 4.12e-04 | 1105 | 116 | 13 | EFO_0004528 |
| Disease | Bardet-Biedl syndrome (implicated_via_orthology) | 8.23e-04 | 11 | 116 | 2 | DOID:1935 (implicated_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | HBS1L AGO2 MYO1D RC3H1 HECTD4 LARP1 CPS1 PARP10 COLEC12 ZKSCAN1 CRYBG1 RP1 PYCR3 HSP90AB1 | 8.36e-04 | 1347 | 116 | 14 | EFO_0005192 |
| Disease | Mitochondrial disease | 9.56e-04 | 49 | 116 | 3 | cv:C0751651 | |
| Disease | Malignant neoplasm of breast | DDX59 SYNE1 CYP24A1 ELP3 AKAP12 FABP7 KCNT2 CHD5 EIF3M VPS13B NOTCH3 HSP90AA1 | 1.08e-03 | 1074 | 116 | 12 | C0006142 |
| Disease | Myeloid Leukemia | 2.25e-03 | 18 | 116 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 2.25e-03 | 18 | 116 | 2 | C0023466 | |
| Disease | venous thromboembolism, fibrinogen measurement | 2.36e-03 | 67 | 116 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | Cannabis use, age at onset | 2.51e-03 | 19 | 116 | 2 | EFO_0004847, EFO_0007585 | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 2.51e-03 | 19 | 116 | 2 | DOID:4928 (is_marker_for) | |
| Disease | Hereditary hearing loss and deafness | 2.68e-03 | 146 | 116 | 4 | cv:C0236038 | |
| Disease | hyperglycemia (biomarker_via_orthology) | 3.06e-03 | 21 | 116 | 2 | DOID:4195 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MDIEKVNSMDLGEFV | 1 | A6NGE7 | |
| EGIASATMFDGAKDM | 441 | Q96P26 | |
| YDDMAAAMKAVTEQG | 21 | P31946 | |
| LEFDSEMVEMAQKLG | 411 | Q96RK4 | |
| EMIGDVFVASFSKSM | 496 | O15013 | |
| FKAAVMEIGRSAEMQ | 1396 | Q96N23 | |
| FQAMTAEGEVTMETS | 681 | Q9Y6Y1 | |
| GTEELFKDDVEGMMS | 1196 | Q8TDI0 | |
| AETLAGVKSQEMVME | 1141 | Q02952 | |
| TNGEVEMDASIMDGK | 71 | Q7L266 | |
| MIKEGSMSEDEFFQE | 446 | P51813 | |
| MKAQQVVKSESGEEM | 206 | Q9NVT9 | |
| MAGDFVNMVEKGIID | 506 | P10809 | |
| EEFVAMMTGESFKLI | 166 | Q8TD86 | |
| GENSEFGEVFKMMQA | 236 | P98194 | |
| ESSQFGEVFKMMQAE | 266 | O75185 | |
| AMEEIDMQQGTSSVK | 1416 | Q96BY7 | |
| QAEEMVEFSSGLKGM | 91 | P25705 | |
| EFGIMVKDEMTDVTG | 396 | Q9UKV8 | |
| SDIITGAQEVEMMTK | 281 | Q8IYR0 | |
| QEFGVNFSVMSSEKM | 481 | Q8IXT5 | |
| DVVAAGSVEMMNVES | 831 | Q5TC82 | |
| TDMAFKTSVAVEMAG | 616 | Q9H0B3 | |
| ERGVTMDVGMTKFET | 321 | Q9Y450 | |
| IEVSGKSLDQVTDMM | 221 | Q9BYG5 | |
| EDGMKLATMAVANGF | 16 | P63252 | |
| MVGQEGSDTSKLEMF | 26 | Q6ZRR7 | |
| AEAQVVMMGLDSAGK | 11 | Q969Q4 | |
| EEMEQMDGRKNTFTA | 611 | Q6PKG0 | |
| KAFMEALQAGADISM | 111 | P08238 | |
| NFEMEGDSEVIMESK | 191 | Q8N128 | |
| SENAMGSTMVEEQFA | 51 | O43292 | |
| IFGTMEEMQNKAVVF | 231 | Q9P035 | |
| NDAFMEVEMAEVTKI | 306 | Q8IUS5 | |
| NEVILFEKMMSGSDI | 631 | Q8NCI6 | |
| ATMDAGKLVSDEMVV | 66 | P54819 | |
| TFMGMAVENKEISFD | 281 | Q7L2H7 | |
| VVDEADTMLKMGFQQ | 351 | Q5T1V6 | |
| FENSIGAVDEMLKTM | 21 | Q13901 | |
| EMDEAKAQGTQMGAE | 121 | A0A1B0GVG4 | |
| VVAMAKESVNAAFEM | 236 | P30084 | |
| DNEKGFDVASMMSVT | 601 | P10515 | |
| VTVMDADKGRNAEMS | 661 | O60245 | |
| VVEKMDNVTGGMETS | 61 | Q5KU26 | |
| NMAKGESLMGEVATD | 1706 | Q9UM47 | |
| QEMMKEIDYDGSGSV | 161 | P23743 | |
| MVDKDQIFMENVGAV | 531 | Q96LU7 | |
| MRESAMQKLGTEVFE | 571 | Q8NG66 | |
| QTDLQKIMGMEFSEE | 111 | O15264 | |
| GVMKSRSNVDMDFEV | 511 | P00488 | |
| KAMDFVSQEQGEMVM | 876 | P42704 | |
| IAANMDTVGTFEMAK | 51 | Q9P2T1 | |
| ISQDVFDEMVNMGKF | 466 | Q96M69 | |
| ANMVVVDKESTMSAE | 796 | Q6UVM3 | |
| MKEVSFDGNDLENMV | 1006 | Q9Y4D8 | |
| FGSQEIMTEKDMELF | 471 | Q92794 | |
| GSAMNVVFSEDEMKK | 1136 | P31327 | |
| GMKDSDMDYVQIDAT | 306 | P83105 | |
| IDDMVAQAMKSEGGF | 251 | O75874 | |
| GSGQMKMFQEVSAAD | 861 | P40189 | |
| TFILNMESMVEGFKV | 606 | Q6ISB3 | |
| AANMMVDFRVSEKES | 61 | P15088 | |
| EAAAKTMMEKNEFVS | 516 | Q6ZP82 | |
| AGDEAVNFIMAIKTM | 231 | Q07973 | |
| ESVMVNISAKAEMIG | 86 | Q9Y6R7 | |
| ASGDFASVQEAMAKM | 496 | Q96C11 | |
| FSEQVAVGETDAKMM | 156 | Q5JV73 | |
| MSFEDIKANVTEMLA | 311 | P05108 | |
| SVDKVEFIVMGGTFM | 161 | Q9H9T3 | |
| MGNVMEGKSVEELSS | 1 | P43080 | |
| AFLGENAEVKEMMTT | 526 | Q6P179 | |
| KEGMGQDEAQFSVEM | 611 | Q8WUQ7 | |
| KAFMEALQAGADISM | 116 | P07900 | |
| KVFMEVLQAGADISM | 56 | Q58FG1 | |
| FDDTEEMQGFGVMQK | 1141 | Q9Y4K1 | |
| VTQMVMGSTFEDDQE | 176 | Q6UW02 | |
| MLSGTVTKVNETEMD | 151 | O75629 | |
| DGKMVMTLTFGDVVA | 111 | O15540 | |
| MGLETEKADVQLFMD | 1 | P51636 | |
| SIMSFLDEMEKSGQD | 531 | Q9UPN4 | |
| KAFMEALQAGADISM | 116 | Q14568 | |
| KSTVIAMMTQEVEGE | 2301 | Q12923 | |
| MVAMAEAEAGVAVEV | 1 | Q53GL7 | |
| KIQVSMMFDGQSAVE | 831 | Q16363 | |
| KSIIFNQDGTMTVEM | 321 | P56715 | |
| SESMKVVAESMGIAQ | 16 | P49848 | |
| SVEEAENVMKFMNET | 576 | Q8NF91 | |
| SIMVTMENFSKEFEE | 261 | A2VDJ0 | |
| MNGVRKDVVMTDSED | 336 | O60502 | |
| MEEVVNEFEPGMATK | 1006 | Q8IWB4 | |
| FMKDHFLMDEQVVGT | 391 | Q9H3S1 | |
| MSMEDPFFVVKGEVQ | 1 | O43752 | |
| KEASDFVGMMLAAAT | 221 | Q96CQ1 | |
| MFQTVDLFEGKDMAA | 111 | Q01995 | |
| QFMDNMSGGKVDEAL | 1241 | Q9UHV7 | |
| MAEGEKNQDFTFKME | 1 | Q86XK3 | |
| EIMNSFAKSIEVMGD | 776 | O60518 | |
| AFSEALAEGAVKMGM | 186 | Q53H96 | |
| EVEKMGAVFMDAPVS | 146 | P31937 | |
| MAGMVDFQDEEQVKS | 1 | Q96BR5 | |
| GAVSKLMESMAAEED | 2106 | O15417 | |
| DMELSFAVQRGMDKV | 296 | Q13064 | |
| MEEVVNEFEPGMATK | 1006 | Q5TZJ5 | |
| MEEVVNEFEPGMATK | 1006 | Q5VU36 | |
| MGQTVNEDSMDVKKE | 1 | Q9UQR0 | |
| VMDALSFVMGEKIAN | 41 | Q8NDV3 | |
| MVDMSEKGTEAGAAS | 361 | Q86U17 | |
| TMIGKAVEHMFETED | 131 | Q9Y657 | |
| AFEEEMEAAMKGLVQ | 126 | Q92543 | |
| SNFTKDMLMEGTEEV | 31 | Q15643 | |
| MGVKDFEENMNRSET | 461 | Q7Z7G8 | |
| ESVMENSKVLGESMA | 1396 | Q9Y4G6 | |
| AASAIGMKMQDVDLF | 436 | Q9HD40 | |
| ADSQAMVKIEDMAVS | 221 | P17029 | |
| ADVVDVAADSMSGMT | 791 | P11498 | |
| MAEEFVTLKDVGMDF | 1 | Q8WTR7 | |
| MNVGKVTDEMFLEAL | 461 | O94832 | |
| PSFKESEMNVIAADM | 426 | Q96BF6 |